Andere Kunden interessierten sich auch für
![HIV/AIDS in U.S. Communities of Color]( "HIV/AIDS in U.S. Communities of Color")
HIV/AIDS in U.S. Communities of Color37,99 €![HIV and AIDS:]( "HIV and AIDS:")
HIV and AIDS:147,99 €![Combination Therapy of AIDS]( "Combination Therapy of AIDS")
Combination Therapy of AIDS125,99 €![In vivo Models of HIV Disease and Control]( "In vivo Models of HIV Disease and Control")
In vivo Models of HIV Disease and Control125,99 €![Health of HIV Infected People]( "Health of HIV Infected People")
Health of HIV Infected People76,99 €![Reverse Transcriptase Inhibitors in Hiv/AIDS Therapy]( "Reverse Transcriptase Inhibitors in Hiv/AIDS Therapy")
Reverse Transcriptase Inhibitors in Hiv/AIDS Therapy245,99 €![Denying AIDS]( "Denying AIDS")
Denying AIDS29,99 €
Cancer incidences increase in people living with HIV/AIDS. Over 2 million people currently live with HIV/AIDS in the US. This number will increase as HAART prolongs the average lifespan and as (at least in some states) the number of new HIV infections increase again. As this population ages their incidence rates for cancer will increase, as well.
Recently, new rational targets for cancer therapy have emerged. But their application to the care of HIV+ patients is slow, because of concerns about the weakened immune status of the patients, because of possible drug interactions with HAART and because some of the AIDS defining cancer are rare.
Recently, new rational targets for cancer therapy have emerged. But their application to the care of HIV+ patients is slow, because of concerns about the weakened immune status of the patients, because of possible drug interactions with HAART and because some of the AIDS defining cancer are rare.